Skip to main content
. Author manuscript; available in PMC: 2010 Feb 1.
Published in final edited form as: Cancer Causes Control. 2008 Aug 15;20(1):27–34. doi: 10.1007/s10552-008-9213-y

Table 1.

Ever Use of Oral Contraceptives and Cancer in the Shanghai Cohort

Cancer Site Ever Use Number of Cases Number of Person-Years RRa 95% CI
All Cancers Combined No 6,669 2,048,373 1.00
Yes 979 352,699 0.94 0.88, 1.01
Breast No 1,496 2,032,357 1.00
Yes 253 350,741 0.90 0.78, 1.03
Colon No 563 2,045,338 1.00
Yes 92 352,851 1.09 0.86, 1.37
Gall bladder No 121 2,045,817 1.00
Yes 10 353,015 0.73 0.38, 1.42
Liver No 420 1,173,637 1.00
Yes 48 1,226,787 0.82b 0.60, 1.13
Lung No 746 2,048,263 1.00
Yes 82 353,284 0.87 0.69, 1.10
Ovary No 254 2,008,845 1.00
Yes 53 349,539 1.17 0.86, 1.60
Pancreas No 208 2,046,309 1.00
Yes 30 353,106 1.11 0.74, 1.66
Rectal No 306 2,045,266 1.00
Yes 62 352,877 1.31 0.98, 1.75
Stomach No 721 2,046,890 1.00
Yes 103 353,051 1.02 0.82, 1.27
Thyroid No 141 2,044,687 1.00
Yes 20 352,876 0.75b 0.46, 1.23
Uterine Cervix No 62 1,983,158 1.00
Yes 1 345,909 0.13 0.02, 0.96
Uterine Corpus No 236 1,982,639 1.00
Yes 27 345,869 0.68b 0.45, 1.04
a

Adjusted for parity and age using linear splines unless otherwise noted

b

Adjusted additionally forever having had a tubal ligation

c

Adjusted additionally for number of induced abortions